Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nimbright International Holding Group AB
AB
Active
Org 5593260200
Topasgatan 77, 421 48
Västra Frölunda
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2021
0 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Nimbright International Holding Group AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2022
1M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2022
2023
2024
Revenue
1 365
682
309
Staff expenses
−3
−0
−9
EBITDA
284
45
−37
Depreciation & amort.
—
—
—
EBIT
284
45
−37
Net financials
−0
0
2
Profit before tax
284
45
−35
Tax
−62
−13
—
Net profit
222
32
−35
Balance sheet
SEK thousands
Item
2022
2023
2024
Total assets
247
302
260
Equity
247
279
244
Long-term debt
—
—
—
Short-term debt
—
23
17
Total debt
—
23
17
Financial ratios
5-year trend
EBITDA margin
-12.1%
This company
15.8%
Market median
-177% vs market
2022
2024
Equity ratio
93.7%
This company
38.2%
Market median
+145% vs market
2022
2024
Return on equity
-14.3%
This company
18.4%
Market median
-178% vs market
2022
2024
Net profit margin
-11.3%
This company
8.1%
Market median
-240% vs market
2022
2024
Asset turnover
1.19×
This company
1.12×
Market median
+6% vs market
2022
2024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-05 – 2022-12-31
View
PDF
More on Nimbright International Holding Group AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
